These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 30314525)

  • 21. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(1):18-24. PubMed ID: 16365567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for mixed hepatocellular and cholangiocellular carcinoma.
    Uenishi T; Hirohashi K; Shuto T; Yamamoto T; Kubo S; Tanaka H; Ikebe T; Kinoshita H
    Hepatogastroenterology; 2000; 47(33):832-4. PubMed ID: 10919041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma.
    Gigante E; Ronot M; Bertin C; Ciolina M; Bouattour M; Dondero F; Cauchy F; Soubrane O; Vilgrain V; Paradis V
    Liver Int; 2019 Dec; 39(12):2386-2396. PubMed ID: 31544304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(2):173-81. PubMed ID: 16628028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Hepatic Carcinosarcoma Composed of Hepatocellular Carcinoma, Cholangiocarcinoma, Osteosarcoma and Rhabdomyosarcoma With Poor Prognosis.
    Liu LI; Ahn E; Studeman K; Campbell K; Lai J
    Anticancer Res; 2020 Apr; 40(4):2225-2229. PubMed ID: 32234918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge.
    Zhou X; Wang J; Tang M; Huang M; Xu L; Peng Z; Li ZP; Feng ST
    BMC Cancer; 2020 Jan; 20(1):54. PubMed ID: 31969123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings.
    Liu QY; Huang SQ; Chen JY; Li HG; Gao M; Liu C; Liang BL
    Abdom Imaging; 2010 Oct; 35(5):537-42. PubMed ID: 19763681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma.
    Aishima S; Kuroda Y; Asayama Y; Taguchi K; Nishihara Y; Taketomi A; Tsuneyoshi M
    Hum Pathol; 2006 Mar; 37(3):283-91. PubMed ID: 16613323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
    Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
    Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
    Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
    BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
    Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
    Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
    Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncommon liver tumors: Case report and literature review.
    Wu CH; Chiu NC; Yeh YC; Kuo Y; Yu SS; Weng CY; Liu CA; Chou YH; Chiou YY
    Medicine (Baltimore); 2016 Sep; 95(39):e4952. PubMed ID: 27684838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
    Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
    Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation.
    Lo EC; N Rucker A; Federle MP
    Semin Radiat Oncol; 2018 Oct; 28(4):267-276. PubMed ID: 30309637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.
    Loyer EM; Chin H; DuBrow RA; David CL; Eftekhari F; Charnsangavej C
    Radiology; 1999 Sep; 212(3):866-75. PubMed ID: 10478259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Iavarone M; Piscaglia F; Vavassori S; Galassi M; Sangiovanni A; Venerandi L; Forzenigo LV; Golfieri R; Bolondi L; Colombo M
    J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
    Choi SH; Lee SS; Kim SY; Park SH; Park SH; Kim KM; Hong SM; Yu E; Lee MG
    Radiology; 2017 Mar; 282(3):771-781. PubMed ID: 27797675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.